Apostolopoulos Vasso, Yu Minmin, Corper Adam L, Teyton Luc, Pietersz Geoffrey A, McKenzie Ian F C, Wilson Ian A, Plebanski Magdalena
Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
J Mol Biol. 2002 May 17;318(5):1293-305. doi: 10.1016/s0022-2836(02)00196-1.
Peptides bind with high affinity to MHC class I molecules by anchoring certain side-chains (anchors) into specificity pockets in the MHC peptide-binding groove. Peptides that do not contain these canonical anchor residues normally have low affinity, resulting in impaired pMHC stability and loss of immunogenicity. Here, we report the crystal structure at 1.6 A resolution of an immunogenic, low-affinity peptide from the tumor-associated antigen MUC1, bound to H-2Kb. Stable binding is still achieved despite small, non-canonical residues in the C and F anchor pockets. This structure reveals how low-affinity peptides can be utilized in the design of novel peptide-based tumor vaccines. The molecular interactions elucidated in this non-canonical low-affinity peptide MHC complex should help uncover additional immunogenic peptides from primary protein sequences and aid in the design of alternative approaches for T-cell vaccines.
肽段通过将某些侧链(锚定残基)嵌入MHC肽结合槽的特异性口袋中,以高亲和力与MHC I类分子结合。不包含这些典型锚定残基的肽段通常亲和力较低,导致pMHC稳定性受损和免疫原性丧失。在此,我们报告了来自肿瘤相关抗原MUC1的一种免疫原性低亲和力肽段与H-2Kb结合的1.6 Å分辨率晶体结构。尽管C和F锚定口袋中有小的非典型残基,仍实现了稳定结合。该结构揭示了低亲和力肽段如何用于设计新型基于肽段的肿瘤疫苗。在这种非典型低亲和力肽段-MHC复合物中阐明的分子相互作用,应有助于从一级蛋白质序列中发现更多免疫原性肽段,并有助于设计T细胞疫苗的替代方法。